pyroglutamylleucine has been researched along with Disease Models, Animal in 2 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, Y; Furuta, S; Hashimoto, K; Itabashi, M; Kiyono, T; Mochizuki, S; Nagata, M; Nakamura, Y; Ono, S; Park, EY; Sakata, Y; Sanada, H; Sato, K; Shimmura, Y; Suzuki, Y | 1 |
| Aoi, W; Bou, Y; Fujiwara, M; Kiyono, T; Naito, Y; Ohta, R; Park, EY; Sato, K; Takagi, T; Wada, E; Wada, S; Yoshikawa, T | 1 |
2 other study(ies) available for pyroglutamylleucine and Disease Models, Animal
| Article | Year |
|---|---|
Identification of a hepatoprotective peptide in wheat gluten hydrolysate against D-galactosamine-induced acute hepatitis in rats.
Topics: Animals; Biomarkers; Dipeptides; Disease Models, Animal; Galactosamine; Glutens; Hepatitis; Peptide Fragments; Protective Agents; Protein Hydrolysates; Pyrrolidonecarboxylic Acid; Rats; Triticum | 2013 |
Ingestion of low dose pyroglutamyl leucine improves dextran sulfate sodium-induced colitis and intestinal microbiota in mice.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Dextran Sulfate; Dipeptides; Disease Models, Animal; Humans; Intestines; Male; Mice; Mice, Inbred C57BL; Microbiota; Pyrrolidonecarboxylic Acid | 2013 |